Literature DB >> 25847422

The impact of chronic Aflatoxin B1 exposure and p53 genotype on base excision repair in mouse lung and liver.

Jeanne E Mulder1, Genevieve S Bondy2, Rekha Mehta2, Thomas E Massey3.   

Abstract

Aflatoxin B1 (AFB1) is produced by species of Aspergillus, and is a known human carcinogen. AFB1-induced oxidative DNA damage, specifically 8-hydroxy-2-deoxyguanosine (8-OHdG) lesions, has been demonstrated in both animal models and in humans, and is repaired by base excision repair (BER). The tumour suppressor gene p53 is implicated in the regulation of DNA repair, and heterozygous p53 knockouts have an attenuated nucleotide excision repair response to AFB1. Male heterozygous p53 knockout mice and their wild-type controls were exposed to 0, 0.2 or 1.0ppm AFB1 for 26 weeks in their diet. BER activity of lung and liver was assessed with an in vitro assay, using 8-OHdG-damaged plasmid DNA as a substrate. BER activity did not differ between livers or lungs from untreated wild-type versus heterozygous p53 knockout mice. In wild-type mice, repair was 65% lower in liver extracts from mice exposed to 1.0ppm AFB1 than in liver extracts from mice exposed to 0.2ppm AFB1 (p<0.05), but not significantly lower than that in liver extracts from control mice. AFB1 did not affect BER in lung extracts from wild-type mice, or in lung and liver extracts from heterozygous p53 knockout mice. In liver and lung, AFB1 exposure did not alter levels of 8-oxoguanine glycosylase protein, a key enzyme in the repair of 8-OHdG, and did not cause hepatotoxicity, as indicated by plasma alanine aminotransferase levels. In conclusion, chronic exposure to AFB1 did not affect BER in lungs or livers of heterozygous p53 knockout mice. BER activity was lower in livers from p53 wild type mice exposed to 1.0ppm AFB1 versus those exposed to 0.2ppm AFB1, an effect that was not attributable to liver cell death or altered levels of 8-oxoguanine glycosylase.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aflatoxin B(1); Base excision repair; Chronic; p53 genotype

Mesh:

Substances:

Year:  2015        PMID: 25847422     DOI: 10.1016/j.mrfmmm.2015.01.015

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  5 in total

1.  Aflatoxin-Guanine DNA Adducts and Oxidatively Induced DNA Damage in Aflatoxin-Treated Mice in Vivo as Measured by Liquid Chromatography-Tandem Mass Spectrometry with Isotope Dilution.

Authors:  Erdem Coskun; Pawel Jaruga; Vladimir Vartanian; Onur Erdem; Patricia A Egner; John D Groopman; R Stephen Lloyd; Miral Dizdaroglu
Journal:  Chem Res Toxicol       Date:  2018-12-19       Impact factor: 3.973

2.  Impact of a Single Oral Acute Dose of Aflatoxin B₁ on Liver Function/Cytokines and the Lymphoproliferative Response in C57Bl/6 Mice.

Authors:  Angélica Tieme Ishikawa; Elisa Yoko Hirooka; Paula Leonello Alvares E Silva; Ana Paula Frederico Rodrigues Loureiro Bracarense; Karina Keller Marques da Costa Flaiban; Claudia Yuri Akagi; Osamu Kawamura; Marcio Carvalho da Costa; Eiko Nakagawa Itano
Journal:  Toxins (Basel)       Date:  2017-11-17       Impact factor: 4.546

3.  Unique Aggregation of Sterigmatocystin in Water Yields Strong and Specific Circular Dichroism Response Allowing Highly Sensitive and Selective Monitoring of Bio-Relevant Interactions.

Authors:  Daniela Jakšić; Maja Šegvić Klarić; Ivo Crnolatac; Nataša Šijaković Vujičić; Vilko Smrečki; Marcin Górecki; Gennaro Pescitelli; Ivo Piantanida
Journal:  Mar Drugs       Date:  2019-11-06       Impact factor: 5.118

Review 4.  p53 in the DNA-Damage-Repair Process.

Authors:  Ashley B Williams; Björn Schumacher
Journal:  Cold Spring Harb Perspect Med       Date:  2016-05-02       Impact factor: 6.915

5.  Fungal Aflatoxins Reduce Respiratory Mucosal Ciliary Function.

Authors:  Robert J Lee; Alan D Workman; Ryan M Carey; Bei Chen; Phillip L Rosen; Laurel Doghramji; Nithin D Adappa; James N Palmer; David W Kennedy; Noam A Cohen
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.